Page last updated: 2024-10-21

3-methylcholanthrene and Ischemic Attack, Transient

3-methylcholanthrene has been researched along with Ischemic Attack, Transient in 1 studies

Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.

Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kirsch, WM1
Schulz, D1
Leitner, JW1

Other Studies

1 other study available for 3-methylcholanthrene and Ischemic Attack, Transient

ArticleYear
The effect of prolonged ischemia upon regional energy reserves in the experimental glioblastoma.
    Cancer research, 1967, Volume: 27, Issue:11

    Topics: Adenosine Triphosphate; Animals; Brain; Brain Chemistry; Fluorometry; Glioma; Glucose; Glycogen; Isc

1967